Fosun Pharma updates on A-share repurchase progress

Shanghai Fosun Pharmaceutical Group (SSE:600196) announced it has made progress on its A-share repurchase program. From April 8 to April 15, 2025, the company repurchased 4,399,252 A shares through centralized bidding, amounting to approximately CNY 10,458.82. The repurchases are part of a larger plan, approved January 22, 2025, to buy back shares worth between CNY 30,000 and CNY 60,000 by July 21, 2025. As of April 15, 2025, the company has repurchased a total of 6,012,552 A shares, representing 0.2251% of the total share capital, for a total of approximately CNY 14,458.23, the price ranging from CNY 23.41 to CNY 25.39 per share. Fosun Pharma intends to continue executing the repurchase program based on market conditions and in accordance with relevant regulations.